EQUITY (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
Equity [Abstract] |
|
Schedule of Warrants Outstanding and Exercisable |
The following table summarizes the status of our warrants and related transactions for each of the presented years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Derivative Warrants |
|
Derivative Warrants |
|
Total Number of Warrants |
|
Weighted - Average Exercise Price Per Warrant |
|
Aggregate Intrinsic Value |
|
Weighted Average Remaining Contractual Life (in Years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2021 (1)
|
36,764,244 |
|
42,017,892 |
|
78,782,136 |
|
$ |
1.31 |
|
|
$ |
358,319 |
|
|
5.3 |
Granted (2)
|
300,000 |
|
— |
|
|
300,000 |
|
$ |
4.18 |
|
|
|
|
|
Exercised |
(7,658,196) |
|
(1,893,537) |
|
(9,551,733) |
|
$ |
2.26 |
|
|
$ |
31,343 |
|
|
|
Cancelled |
(250,000) |
|
— |
|
|
(250,000) |
|
$ |
1.50 |
|
|
|
|
|
Balance, December 31, 2021 |
29,156,048 |
|
40,124,355 |
|
69,280,403 |
|
$ |
1.19 |
|
|
$ |
142,791 |
|
|
4.7 |
Granted (2)(3)
|
1,600,000 |
|
|
19,512,280 |
|
|
21,112,280 |
|
|
$ |
2.06 |
|
|
|
|
|
Exercised |
(82,413) |
|
|
(4,261,433) |
|
|
(4,343,846) |
|
|
$ |
1.26 |
|
|
$ |
9,746 |
|
|
|
Balance, December 31, 2022 |
30,673,635 |
|
55,375,202 |
|
86,048,837 |
|
$ |
1.40 |
|
|
$ |
1,081 |
|
|
3.9 |
Exercisable, December 31, 2022 |
28,323,635 |
|
55,375,202 |
|
83,698,837 |
|
$ |
1.38 |
|
|
$ |
1,081 |
|
|
3.9 |
(1)Total number of outstanding warrants reflects the conversion of warrants to acquire Super Voting Shares and Multi-Voting shares into warrants to acquire Subordinate Voting Shares.
(2)The non-derivative warrants were issued for consulting or other services, therefore, these compensatory warrants are accounted for as share-based payment arrangements.
(3)Derivative warrants were issued to the Second Lien Notes Holders and the Acquisition Facility Lender. Refer to Note 14 - Derivative Liabilities for more information.
|
Schedule of Share-Based Payment Award, Warrants, Valuation Assumptions |
The following assumptions were used for the calculations at date of issuance.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2022 |
|
2021 |
|
2020 |
|
|
|
|
|
|
Weighted average stock price |
$1.74 |
|
$4.18 |
|
$2.08 |
Weighted average expected stock price volatility |
81% |
|
73% |
|
81% |
Expected annual dividend yield |
—% |
|
—% |
|
—% |
Weighted average expected life of warrants |
5.0 years |
|
3.5 years |
|
2.7 years |
Weighted average risk-free annual interest rate |
3.48% |
|
1.06% |
|
0.35% |
Weighted average grant date fair value |
$1.13 |
|
$2.14 |
|
$1.00 |
|
Summary of Stock Options Outstanding |
The following table summarizes the status of the Company’s options and related transactions for each of the presented years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Options |
|
Weighted Average Exercise Price per Stock Options |
|
Aggregate Intrinsic Value |
|
Weighted Average Remaining Contractual Life (in Years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2021 |
9,573,834 |
|
|
$ |
2.00 |
|
|
$ |
36,909 |
|
|
8.4 |
Granted |
11,486,952 |
|
|
$ |
4.16 |
|
|
|
|
|
Exercised |
(291,664) |
|
|
$ |
1.90 |
|
|
$ |
881 |
|
|
|
Forfeited/expired |
(340,002) |
|
|
$ |
3.23 |
|
|
|
|
|
Balance, December 31, 2021 |
20,429,120 |
|
|
$ |
3.20 |
|
|
$ |
11,583 |
|
|
8.7 |
Granted |
13,686,806 |
|
|
$ |
1.95 |
|
|
|
|
|
Exercised |
(324,998) |
|
|
$ |
1.67 |
|
|
$ |
620 |
|
|
|
Forfeited/expired |
(3,038,669) |
|
|
$ |
4.02 |
|
|
|
|
|
Balance, December 31, 2022 |
30,752,259 |
|
|
$ |
2.58 |
|
|
$ |
— |
|
|
8.5 |
Exercisable, December 31, 2022 |
12,166,594 |
|
|
$ |
2.46 |
|
|
$ |
— |
|
|
7.2 |
|
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions |
The following assumptions were used for the calculation at date of grant:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2022 |
|
2021 |
|
2020 |
|
|
|
|
|
|
Weighted average stock price |
$1.95 |
|
$4.16 |
|
$2.78 |
Weighted average expected stock price volatility |
74.1% |
|
73.0% |
|
80.9% |
Expected annual dividend yield |
—% |
|
—% |
|
—% |
Weighted average expected life |
5.7 years |
|
6.0 years |
|
5.9 years |
Weighted average risk-free annual interest rate |
2.88% |
|
1.23% |
|
0.52% |
Weighted average grant date fair value |
$1.35 |
|
$2.61 |
|
$1.78 |
|
Summary of Restricted Stock Activity |
The following table summarized the status of our restricted stock and related transactions for each presented years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unvested Restricted Stock |
|
Weighted-Average Grant-date Fair Value Price per Restricted Stock |
|
Average Intrinsic Value |
|
Weighted Average Remaining Vesting Term (in Years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued and Outstanding as of January 1, 2021 |
6,438,186 |
|
$ |
1.85 |
|
|
$ |
37,728 |
|
|
1.7 |
|
|
|
Granted |
65,398 |
|
$ |
3.66 |
|
|
|
|
|
|
|
|
Vested and Released |
(3,424,954) |
|
$ |
1.63 |
|
|
$ |
14,251 |
|
|
|
|
|
|
Cancelled |
(219,479) |
|
$ |
2.45 |
|
|
|
|
|
|
|
|
Issued and Outstanding as of December 31, 2021 |
2,859,151 |
|
$ |
2.13 |
|
|
$ |
9,292 |
|
|
1.2 |
|
|
|
Granted |
86,952 |
|
|
$ |
2.05 |
|
|
|
|
|
|
|
|
Vested and Released |
(1,789,784) |
|
|
$ |
1.96 |
|
|
$ |
3,601 |
|
|
|
|
|
|
Issued and Outstanding as of December 31, 2022 |
1,156,319 |
|
|
$ |
2.45 |
|
|
$ |
881 |
|
|
0.3 |
|
|
|
|
Components of Share-based Compensation Expense |
As of December 31, 2022, the Company had $19,246 of unrecognized share-based compensation cost related to unvested stock options, restricted stocks and warrants and is expected to be recognized as share-based compensation cost over a weighted average period of 1.4 years as follows:
|
|
|
|
|
|
2023 |
$ |
13,485 |
|
2024 |
4,333 |
|
2025 |
1,128 |
|
2026 |
275 |
|
2027 |
25 |
|
|
$ |
19,246 |
|
|